Peptides

You have probably seen Selank described in nootropic forums as the Russian government's answer to anxiety — an approved drug that sidesteps benzodiazepine dependence while also improving cognition. That narrative is compelling enough that it drives a meaningful grey-market trade in vials of unknown purity shipped from unregulated suppliers. The obvious follow-up question is whether […]

If you have severe osteoporosis, you have probably heard that most bone drugs work by slowing breakdown rather than building new bone. That framing is mostly accurate, and it is exactly why teriparatide gets attention: it works in the other direction. But is it for everyone with low bone density? Almost certainly not. And is

Synthetic oxytocin is the same nine-amino-acid molecule whether it arrives in an IV bag hanging above a labor-and-delivery bed or in a small amber bottle mailed from a compounding pharmacy. The FDA-approved version, sold under the brand name Pitocin, has been used in hospital obstetric wards since the 1960s, backed by decades of clinical data

You may have come across octreotide in a bodybuilding forum or a wellness thread with the vague framing that it "blocks GH" or helps with "spot reduction." That framing is worth pausing on, because octreotide is a serious prescription drug with a specific set of FDA-approved indications, a well-documented side-effect profile, and zero clinical evidence

Tesamorelin has one thing no other GHRH analog peptide can claim: an FDA approval. That approval is real, the Phase 3 trial data behind it are solid, and the mechanism is well understood. But the indication is narrow — HIV-associated lipodystrophy, specifically the excess visceral fat that accumulates in people on long-term antiretroviral therapy —

If you or someone you care for has been prescribed Lupron — or if you have seen leuprolide mentioned in the context of prostate cancer, endometriosis, or early puberty in a child — you have probably wondered how a single drug ends up treating three conditions that appear to have nothing in common. The honest

Every peptide article eventually circles back to the same molecule. When researchers argue that peptide drugs can be both precise and safe, they point to a century of clinical data. When skeptics ask whether synthetic chains of amino acids can actually replace a biological function, the answer is yes — and it has been yes

Bottom line Zepbound (tirzepatide) demonstrated a greater average weight reduction of 20.2% compared to Wegovy (semaglutide) at 13.7% over 72 weeks in a head-to-head trial. This 6.5 percentage-point difference was both statistically and clinically significant. Comparison Factors: Beyond average weight loss, consider side-effect tolerance, drug mechanism, insurance coverage, and prescriber comfort. Regulatory Status: Both Wegovy

Everyone seems to have an opinion about which drug is better. Endocrinologists debate trial endpoints. Reddit threads run for hundreds of comments comparing injections and nausea episodes. Pharmacies can barely keep either in stock. If you have been prescribed one of these medications — or are trying to understand a conversation your doctor is having

If you are researching CJC-1295 and ipamorelin, you have probably read that stacking these two peptides is the "gold standard" for growth hormone optimization. That claim is circulating in forums, fitness podcasts, and grey-market vendor copy with a confidence the published literature does not support. So before this article explains the pharmacology, here is the